Core Viewpoint - The company, Boji Pharmaceutical (300404.SZ), is a specialized CRO service provider focused on offering outsourced pharmaceutical research and development services, currently not engaged in any projects related to Chikungunya virus disease [1] Group 1 - The company provides pharmaceutical R&D outsourcing services and charges technical service fees [1] - There are currently no ongoing projects related to Chikungunya virus disease [1]

Group 1 - The company, Boji Pharmaceutical (300404.SZ), is a professional CRO service provider that primarily offers outsourced pharmaceutical research and development services and charges technical service fees [1] - Currently, the company does not have any projects related to Chikungunya virus disease [1]

Core Viewpoint - The company, Boji Pharmaceutical (300404.SZ), is a specialized CRO service provider primarily offering outsourced pharmaceutical research and development services and charging technical service fees. Currently, the company's overseas business accounts for a small proportion of its overall operations [1]. Group 1 - The company focuses on providing CRO services to pharmaceutical enterprises [1] - The primary revenue model involves charging technical service fees for its services [1] - The company's international business presence is limited at this stage [1]

Group 1 - The company, Boji Pharmaceutical, is a professional CRO service provider primarily offering outsourced pharmaceutical research and development services [1] - The company's current drug pipeline focuses on innovative drugs, including chemical drugs, biological drugs, and traditional Chinese medicine, covering various therapeutic areas [1] - Additionally, the company provides clinical trial and registration application services related to medical devices [1]

（文章来源：证券日报） 证券日报网讯 7月29日晚间，博济医药发布公告称，近日，公司获得国家知识产权局颁发的两项发明专 利证书，分别为"一种托匹司他的制备方法"和"一种鞣酸小檗碱口服制剂及其制备方法"。 ...

证券日报网讯博济医药7月29日在互动平台回答投资者提问时表示，公司有多个处于不同阶段的自研项 目，该类项目由公司自主立项，拥有自主知识产权，例如用于治疗慢性心力衰竭的中药1.2类品种"CRA （原料）"及"CRA片（制剂）"，目前已获得国家药品监督管理局核准签发的《药物临床试验批准通知 书》。 （文章来源：证券日报） ...

Group 1 - The company, Boji Pharmaceutical, is a professional CRO (Contract Research Organization) service provider [2] - It primarily offers outsourced pharmaceutical research and development services to pharmaceutical companies [2] - The company generates revenue by charging technical service fees [2]

Core Insights - The company, Boji Pharmaceutical, has collaborated with over 900 clinical trial service organizations as of the 2024 fiscal year, indicating a strong network in the clinical research sector [2] - Most top-tier hospitals have engaged in partnerships with the company, showcasing its extensive reach and credibility within the healthcare industry [2] Company Summary - Boji Pharmaceutical has established partnerships with more than 900 clinical trial service organizations [2] - The company has collaborated with a majority of top-tier hospitals, enhancing its operational capabilities and market presence [2]

Core Insights - The company, Boji Pharmaceutical, has a significant client base primarily consisting of medium to large domestic pharmaceutical enterprises, having served over 2,000 pharmaceutical companies [2] Company Overview - Boji Pharmaceutical has established itself as a key service provider in the pharmaceutical industry, indicating a strong market presence and extensive experience in the sector [2] - The company's interaction with a diverse range of clients suggests a robust operational capacity and adaptability to various client needs within the pharmaceutical landscape [2] Industry Context - The pharmaceutical industry in China is characterized by a large number of medium to large enterprises, highlighting the competitive nature of the market [2] - The service model employed by Boji Pharmaceutical reflects a trend towards specialized support for pharmaceutical companies, which may enhance operational efficiencies and innovation within the industry [2]

Core Viewpoint - The company, Boji Pharmaceutical, reported that its subsidiary, Jiutai Medical Equipment, is successfully engaged in clinical trials and registration services related to medical devices [2] Company Summary - Boji Pharmaceutical's subsidiary, Jiutai Medical Equipment, is primarily focused on clinical trials and registration application services for medical devices [2] - The company indicated that all business operations are progressing smoothly [2]